Reengineering the national clinical and translational research enterprise

The strategic plan of the national clinical and translational science awards consortium

Steven E. Reis, Lars Berglund, Gordon R. Bernard, Robert M. Califf, Garret A. Fitzgerald, Peter C. Johnson

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Advances in human health require the efficient and rapid translation of scientific discoveries into effective clinical treatments; this process, in turn, depends on observational data gathered from patients, communities, and public health research that can be used to guide basic scientific investigation. Such bidirectional translational science, however, faces unprecedented challenges due to the rapid pace of scientific and technological development, as well as the difficulties of negotiating increasingly complex regulatory and commercial environments that overlap the research domain. Further, numerous barriers to translational science have emerged among the nation's academic research centers, including basic structural and cultural impediments to innovation and collaboration, shortages of trained investigators, and inadequate funding.To address these serious and systemic problems, in 2006 the National Institutes of Health created the Clinical and Translational Science Awards (CTSA) program, which aims to catalyze the transformation of biomedical research at a national level, speeding the discovery and development of therapies, fostering collaboration, engaging communities, and training succeeding generations of clinical and translational researchers. The authors report in detail on the planning process, begun in 2008, that was used to engage stakeholders and to identify, refine, and ultimately implement the CTSA program's overarching strategic goals. They also discuss the implications and likely impact of this strategic planning process as it is applied among the nation's academic health centers.

Original languageEnglish (US)
Pages (from-to)463-469
Number of pages7
JournalAcademic Medicine
Volume85
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Translational Medical Research
science
planning process
health
Research
Research Personnel
clinical treatment
Foster Home Care
Negotiating
Health
National Institutes of Health (U.S.)
strategic planning
technical development
community
shortage
Biomedical Research
Public Health
public health
funding
stakeholder

ASJC Scopus subject areas

  • Medicine(all)
  • Education

Cite this

Reengineering the national clinical and translational research enterprise : The strategic plan of the national clinical and translational science awards consortium. / Reis, Steven E.; Berglund, Lars; Bernard, Gordon R.; Califf, Robert M.; Fitzgerald, Garret A.; Johnson, Peter C.

In: Academic Medicine, Vol. 85, No. 3, 03.2010, p. 463-469.

Research output: Contribution to journalArticle

Reis, Steven E. ; Berglund, Lars ; Bernard, Gordon R. ; Califf, Robert M. ; Fitzgerald, Garret A. ; Johnson, Peter C. / Reengineering the national clinical and translational research enterprise : The strategic plan of the national clinical and translational science awards consortium. In: Academic Medicine. 2010 ; Vol. 85, No. 3. pp. 463-469.
@article{4adb42811d6c4451a4a8334020bb2334,
title = "Reengineering the national clinical and translational research enterprise: The strategic plan of the national clinical and translational science awards consortium",
abstract = "Advances in human health require the efficient and rapid translation of scientific discoveries into effective clinical treatments; this process, in turn, depends on observational data gathered from patients, communities, and public health research that can be used to guide basic scientific investigation. Such bidirectional translational science, however, faces unprecedented challenges due to the rapid pace of scientific and technological development, as well as the difficulties of negotiating increasingly complex regulatory and commercial environments that overlap the research domain. Further, numerous barriers to translational science have emerged among the nation's academic research centers, including basic structural and cultural impediments to innovation and collaboration, shortages of trained investigators, and inadequate funding.To address these serious and systemic problems, in 2006 the National Institutes of Health created the Clinical and Translational Science Awards (CTSA) program, which aims to catalyze the transformation of biomedical research at a national level, speeding the discovery and development of therapies, fostering collaboration, engaging communities, and training succeeding generations of clinical and translational researchers. The authors report in detail on the planning process, begun in 2008, that was used to engage stakeholders and to identify, refine, and ultimately implement the CTSA program's overarching strategic goals. They also discuss the implications and likely impact of this strategic planning process as it is applied among the nation's academic health centers.",
author = "Reis, {Steven E.} and Lars Berglund and Bernard, {Gordon R.} and Califf, {Robert M.} and Fitzgerald, {Garret A.} and Johnson, {Peter C.}",
year = "2010",
month = "3",
doi = "10.1097/ACM.0b013e3181ccc877",
language = "English (US)",
volume = "85",
pages = "463--469",
journal = "Academic Medicine",
issn = "1040-2446",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Reengineering the national clinical and translational research enterprise

T2 - The strategic plan of the national clinical and translational science awards consortium

AU - Reis, Steven E.

AU - Berglund, Lars

AU - Bernard, Gordon R.

AU - Califf, Robert M.

AU - Fitzgerald, Garret A.

AU - Johnson, Peter C.

PY - 2010/3

Y1 - 2010/3

N2 - Advances in human health require the efficient and rapid translation of scientific discoveries into effective clinical treatments; this process, in turn, depends on observational data gathered from patients, communities, and public health research that can be used to guide basic scientific investigation. Such bidirectional translational science, however, faces unprecedented challenges due to the rapid pace of scientific and technological development, as well as the difficulties of negotiating increasingly complex regulatory and commercial environments that overlap the research domain. Further, numerous barriers to translational science have emerged among the nation's academic research centers, including basic structural and cultural impediments to innovation and collaboration, shortages of trained investigators, and inadequate funding.To address these serious and systemic problems, in 2006 the National Institutes of Health created the Clinical and Translational Science Awards (CTSA) program, which aims to catalyze the transformation of biomedical research at a national level, speeding the discovery and development of therapies, fostering collaboration, engaging communities, and training succeeding generations of clinical and translational researchers. The authors report in detail on the planning process, begun in 2008, that was used to engage stakeholders and to identify, refine, and ultimately implement the CTSA program's overarching strategic goals. They also discuss the implications and likely impact of this strategic planning process as it is applied among the nation's academic health centers.

AB - Advances in human health require the efficient and rapid translation of scientific discoveries into effective clinical treatments; this process, in turn, depends on observational data gathered from patients, communities, and public health research that can be used to guide basic scientific investigation. Such bidirectional translational science, however, faces unprecedented challenges due to the rapid pace of scientific and technological development, as well as the difficulties of negotiating increasingly complex regulatory and commercial environments that overlap the research domain. Further, numerous barriers to translational science have emerged among the nation's academic research centers, including basic structural and cultural impediments to innovation and collaboration, shortages of trained investigators, and inadequate funding.To address these serious and systemic problems, in 2006 the National Institutes of Health created the Clinical and Translational Science Awards (CTSA) program, which aims to catalyze the transformation of biomedical research at a national level, speeding the discovery and development of therapies, fostering collaboration, engaging communities, and training succeeding generations of clinical and translational researchers. The authors report in detail on the planning process, begun in 2008, that was used to engage stakeholders and to identify, refine, and ultimately implement the CTSA program's overarching strategic goals. They also discuss the implications and likely impact of this strategic planning process as it is applied among the nation's academic health centers.

UR - http://www.scopus.com/inward/record.url?scp=77649228071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649228071&partnerID=8YFLogxK

U2 - 10.1097/ACM.0b013e3181ccc877

DO - 10.1097/ACM.0b013e3181ccc877

M3 - Article

VL - 85

SP - 463

EP - 469

JO - Academic Medicine

JF - Academic Medicine

SN - 1040-2446

IS - 3

ER -